|
5th Annual RAS-Targeted Drug Development Summit
Conference in-person 26th to 28th September 2023 Boston, Massachusetts, United States of America Website: http://go.evvnt.com/1729218-0?pid=80 Contact person: Caitlin Crouch With the approval of the second-ever KRAS G12C inhibitor, the field can once again celebrate irrevocable proof that RAS is druggable! Time: 08:30 - 18:00. Prices: USD 2599.00 - USD 6046.00. Organized by: Hanson Wade Check the event website for more details. View all events from this organizer.
Events with same date and place Targeted Radiopharmaceuticals Manufacturing and Supply Chain Summit 2nd mRNA Process Development And Manufacturing Summit |
